Clinical Trial Update: BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)

View source ↗

Summary

Post-marketing surveillance study of BONVIVA (ibandronate) Injection has completed, documenting ongoing safety monitoring in osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Status: COMPLETED